AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2019
Feb 4, 2019
33422_dirs_2019-02-04_aa23422b-bf4d-4d0a-a844-250fd87c3510.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2019-01-30
Reporting Person: AMELIO GILBERT F (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-30 | Common Stock | S | 16953 | $5.00 | Disposed | 167661 | Direct |
| 2019-01-31 | Common Stock | S | 13047 | $5.00 | Disposed | 154614 | Direct |
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21